Clinical Trials Browser

Phase 1/2 × Multiple Endocrine Neoplasia Type 1 × Clear all

NCT06542237 2026-02-13

Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Phase 1/2 Recruiting

Multiple Endocrine Neoplasia Type 1

NCT04530916 2025-11-17

WB2020

Phase 1/2 Active not recruiting

Cardiovascular Diseases, Hypertension, Multiple Endocrine Neoplasia Type 1, Atherosclerosis

NCT02072252 2017-08-17

TODAY!

Phase 1/2 Withdrawn

Generalized Anxiety Disorder, Alzheimer Disease, Anxiety Disorders, Bisexuality, Depression, Homosexuality, Multiple Endocrine Neoplasia Type 1

NCT01442571 2011-09-28

Hyaluronic Acid Injection Post Arthroscopy - Does it Improve Immediate Function? Double Blind Controlled Prospective Study

Phase 1/2 Unknown

Multiple Endocrine Neoplasia Type 1